Department of Ocean Sciences, Memorial University of Newfoundland, St. John's, NL, A1C 5S7, Canada.
Aquatic Research Cluster, CREAIT Network, Ocean Sciences Centre, Memorial University of Newfoundland, St. John's, NL, A1C 5S7, Canada.
Mar Biotechnol (NY). 2020 Apr;22(2):263-284. doi: 10.1007/s10126-020-09950-x. Epub 2020 Feb 10.
The optimal dietary requirement of omega-3 long-chain polyunsaturated fatty acids (ω3 LC-PUFA), namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), for Atlantic salmon that promotes growth and health warrants careful investigation. We used 44K microarrays to study the influence of increasing levels of dietary DHA + EPA (0, 1.0, and 1.4% of the diet, as formulated) in the presence of high linoleic acid (LA) on Atlantic salmon growth and liver transcriptome. After a 14-week feeding trial, Atlantic salmon fed diet ω3LC0 (i.e. 0% of DHA + EPA) showed significantly lower final weight and weight gain, and higher feed conversion ratio compared with ω3LC1.0 and ω3LC1.4 diet groups. The microarray experiment identified 55 and 77 differentially expressed probes (Rank Products analyses; PFP < 10%) in salmon fed diets ω3LC1.4 and ω3LC1.0 compared with those fed diet ω3LC0, respectively. The comparison between ω3LC1.4 and ω3LC1.0 revealed 134 differentially expressed probes. The microarray results were confirmed by qPCR analyses of 22 microarray-identified transcripts. Several key genes involved in fatty acid metabolism including LC-PUFA synthesis were upregulated in fish fed ω3LC0 compared with both other groups. Hierarchical clustering and linear regression analyses of liver qPCR and fatty acid composition data demonstrated significant correlations. In the current study, 1.0% ω3 LC-PUFA seemed to be the minimum requirement for Atlantic salmon based on growth performance; however, multivariate statistical analyses (PERMANOVA and SIMPER) showed that fish fed ω3LC1.0 and ω3LC1.4 diets had similar hepatic fatty acid profiles but marked differences in the transcript expression of biomarker genes involved in redox homeostasis (mgst1), immune responses (mxb, igmb, irf3, lect2a, srk2, and lyz2), and LC-PUFA synthesis (srebp1, fadsd5, and elovl2). This research has provided new insights into dietary requirement of DHA and EPA and their impact on physiologically important pathways in addition to lipid metabolism in Atlantic salmon.
ω3 长链多不饱和脂肪酸(ω3 LC-PUFA),即二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)对促进大西洋鲑鱼生长和健康的最佳饮食需求值得仔细研究。我们使用 44K 微阵列研究了在高亚油酸(LA)存在下,饮食中增加 DHA+EPA(按配方计为饮食的 0、1.0 和 1.4%)水平对大西洋鲑鱼生长和肝脏转录组的影响。经过 14 周的喂养试验,与 ω3LC1.0 和 ω3LC1.4 饮食组相比,喂食 ω3LC0 饮食(即 DHA+EPA 为 0%)的大西洋鲑鱼的终重和增重显著降低,饲料转化率更高。微阵列实验确定了在喂食 ω3LC1.4 和 ω3LC1.0 饮食的鲑鱼与喂食 ω3LC0 饮食的鲑鱼相比,分别有 55 个和 77 个差异表达探针(Rank Products 分析;PFP<10%)。ω3LC1.4 与 ω3LC1.0 之间的比较显示有 134 个差异表达探针。通过对 22 个微阵列鉴定的转录本的 qPCR 分析,验证了微阵列结果。与其他两组相比,在喂食 ω3LC0 的鱼中,涉及脂肪酸代谢的几个关键基因,包括 LC-PUFA 合成,上调。对肝脏 qPCR 和脂肪酸组成数据的层次聚类和线性回归分析表明存在显著相关性。在本研究中,基于生长性能,1.0%ω3 LC-PUFA 似乎是大西洋鲑鱼的最低需求;然而,多元统计分析(PERMANOVA 和 SIMPER)表明,喂食 ω3LC1.0 和 ω3LC1.4 饮食的鱼具有相似的肝脂肪酸谱,但参与氧化还原稳态(mgst1)、免疫反应(mxb、igmb、irf3、lect2a、srk2 和 lyz2)和 LC-PUFA 合成(srebp1、fadsd5 和 elovl2)的生物标志物基因的转录表达存在显著差异。这项研究为 DHA 和 EPA 的饮食需求及其对大西洋鲑鱼脂质代谢以外的生理重要途径的影响提供了新的见解。